Literature DB >> 3521998

Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: a cyclosporine A associated side effect.

R A Stahl, L Kanz, B Maier, P Schollmeyer.   

Abstract

In four out of 23 renal transplant recipients treated with cyclosporine A (CyA) and prednisone, hyperchloremic metabolic acidosis with high serum potassium was detected. The patients with metabolic acidosis had a normal anion gap and they all had a urine pH less than 6.0. Plasma renin activity (PRA) was in the low normal range and serum aldosterone in the normal range. Following reduction of the CyA dose, serum bicarbonate increased, serum chloride and serum potassium fell. None of these parameters, however, became normal. Because of morphological changes and sustained reduced renal function, two patients were switched from CyA to azathioprine plus prednisone. Within two weeks after switching, serum bicarbonate, serum chloride, and serum potassium normalized. These data suggest, that CyA induces dose dependent hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521998

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

1.  American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 8.237

2.  Effect of oral cyclosporin on renal function in Crohn's disease.

Authors:  A J Lobo; L D Juby; A H Smith; P N Foster; J Rothwell; J Pentith; T W Poole; A T Axon
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

Review 3.  Regulated acid-base transport in the collecting duct.

Authors:  Carsten A Wagner; Olivier Devuyst; Soline Bourgeois; Nilufar Mohebbi
Journal:  Pflugers Arch       Date:  2009-03-07       Impact factor: 3.657

Review 4.  Adverse reactions and interactions of cyclosporin.

Authors:  J P Scott; T W Higenbottam
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

Review 5.  The Many Faces of Calcineurin Inhibitor Toxicity-What the FK?

Authors:  Samira S Farouk; Joshua L Rein
Journal:  Adv Chronic Kidney Dis       Date:  2020-01       Impact factor: 3.620

Review 6.  Endocrine and metabolic abnormalities following kidney transplantation.

Authors:  W H Hörl; W Riegel; C Wanner; M Haag-Weber; P Schollmeyer; H Wieland; H Wilms
Journal:  Klin Wochenschr       Date:  1989-09-01

7.  [Kidney function of patients with healthy kidneys during cyclosporin treatment].

Authors:  P Heering; B Kutkuhn; G Kreuzpaintner; T Reinhard; R Sundmacher; B Grabensee
Journal:  Klin Wochenschr       Date:  1991-11-26

Review 8.  Ammonia transport in the kidney by Rhesus glycoproteins.

Authors:  I David Weiner; Jill W Verlander
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

9.  Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.

Authors:  Jean-Philippe Bertocchio; Coralie Barbe; Sylvie Lavaud; Olivier Toupance; Pierre Nazeyrollas; Frederic Jaisser; Philippe Rieu
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

10.  Type 4 renal tubular acidosis in a kidney transplant recipient.

Authors:  Manjunath Kulkarni
Journal:  Biomed J       Date:  2016-03-29       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.